Hideharu Kimura

3.5k total citations
113 papers, 2.6k citations indexed

About

Hideharu Kimura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hideharu Kimura has authored 113 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 60 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Hideharu Kimura's work include Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (21 papers) and Colorectal Cancer Treatments and Studies (17 papers). Hideharu Kimura is often cited by papers focused on Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (21 papers) and Colorectal Cancer Treatments and Studies (17 papers). Hideharu Kimura collaborates with scholars based in Japan, United States and United Kingdom. Hideharu Kimura's co-authors include Kazuto Nishio, Kazuo Kasahara, Tomohide Tamura, Tokuzo Arao, Hideo Kunitoh, Takashi Sone, Kazuko Sakai, Yoshihiko Fujita, Makoto Kawaishi and Brian R. Holloway and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hideharu Kimura

108 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideharu Kimura Japan	26	1.5k	1.4k	825	742	272	113	2.6k
Hiroaki Asano Japan	28	1.4k 0.9×	1.1k 0.8×	1.3k 1.5×	842 1.1×	170 0.6×	82	2.8k
Iacopo Petrini Italy	27	723 0.5×	1.0k 0.7×	884 1.1×	688 0.9×	140 0.5×	91	2.5k
Jin-Haeng Chung South Korea	35	2.4k 1.6×	1.6k 1.2×	1.1k 1.3×	810 1.1×	502 1.8×	142	3.7k
Ian Lorimer Canada	17	1.6k 1.0×	1.6k 1.1×	888 1.1×	454 0.6×	252 0.9×	28	2.6k
Shyhmin Huang United States	23	1.0k 0.7×	1.5k 1.1×	1.1k 1.3×	291 0.4×	380 1.4×	39	2.4k
Michael Allgäuer Germany	23	794 0.5×	790 0.6×	438 0.5×	489 0.7×	298 1.1×	67	1.9k
Hirofumi Uehara Japan	22	1.2k 0.8×	805 0.6×	888 1.1×	665 0.9×	181 0.7×	79	2.2k
Genichiro Ishii Japan	30	1.3k 0.9×	997 0.7×	588 0.7×	425 0.6×	332 1.2×	95	2.6k
Hee Eun Lee South Korea	29	707 0.5×	1.3k 1.0×	1.0k 1.2×	680 0.9×	453 1.7×	86	2.7k
Haruhiro Yukiue Japan	29	1.1k 0.7×	812 0.6×	839 1.0×	352 0.5×	134 0.5×	71	2.0k

Countries citing papers authored by Hideharu Kimura

Since Specialization

Citations

This map shows the geographic impact of Hideharu Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Kimura more than expected).

Fields of papers citing papers by Hideharu Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideharu Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Kimura. The network helps show where Hideharu Kimura may publish in the future.

Co-authorship network of co-authors of Hideharu Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Kimura. A scholar is included among the top collaborators of Hideharu Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Kimura. Hideharu Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwasaku, Masahiro, Junji Uchino, Takahiro Yamada, et al.. (2023). Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial. Cancer Medicine. 12(14). 15117–15127. 3 indexed citations

Hara, Johsuke, Yoshihiro Takeda, Takafumi Kobayashi, et al.. (2023). Bronchial Thermoplasty Attenuates Cough Reflex Sensitivity in Severe Asthma : A Single-Center Retrospective Study with 2-year Follow-up. The Journal of Medical Investigation. 70(1.2). 271–275. 1 indexed citations

Yamada, Tadaaki, Yasuhiro Gotô, Hiroshi Tanaka, et al.. (2023). A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study. European Journal of Cancer. 195. 113373–113373. 8 indexed citations

Hara, Satoshi, et al.. (2023). Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma. Internal Medicine. 63(14). 2089–2096. 1 indexed citations

Tanimura, Keiko, Junji Uchino, Hideharu Kimura, et al.. (2023). Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial. The Oncologist. 28(6). 551–e454. 6 indexed citations

Morimoto, Kenji, Ryo Sawada, Tadaaki Yamada, et al.. (2022). A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC. JTO Clinical and Research Reports. 3(9). 100388–100388. 5 indexed citations

Yatabe, Yasushi, Kuniko Sunami, Kōichi Goto, et al.. (2020). Multiplex gene‐panel testing for lung cancer patients. Pathology International. 70(12). 921–931. 36 indexed citations

Hara, Johsuke, Takafumi Kobayashi, Noriyuki Ohkura, et al.. (2019). The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO 2018. The Journal of Medical Investigation. 66(1.2). 157–164. 15 indexed citations

Takano, Toshimi, Junji Tsurutani, Masato Takahashi, et al.. (2018). A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP. The Breast. 40. 67–75. 32 indexed citations

10.

Abo, Miki, Hazuki Takato, Satoshi Watanabe, et al.. (2017). Immunoglobulin G4-related disease preceded by lung involvement. Medicine. 96(24). e7086–e7086. 3 indexed citations

11.

Nagai, Tomoyuki, Tokuzo Arao, Kazuto Nishio, et al.. (2016). Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma. Digestive Diseases. 34(6). 702–707. 17 indexed citations

12.

Kato, Hiroaki, Tokuzo Arao, Kazuko Matsumoto, et al.. (2013). Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma. International Journal of Oncology. 42(4). 1151–1158. 73 indexed citations

13.

Fujita, Yoshihiko, Kenichi Suda, Hideharu Kimura, et al.. (2012). Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation. Journal of Thoracic Oncology. 7(11). 1640–1644. 99 indexed citations

14.

Kasahara, Kazuo, Tohru Ohmori, Hideharu Kimura, et al.. (2012). MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity. Journal of Thoracic Oncology. 7(9). 1337–1344. 20 indexed citations

15.

Nagai, Tomoyuki, Tokuzo Arao, Kazuyuki Furuta, et al.. (2011). Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 10(1). 169–177. 101 indexed citations

16.

Nishio, Makoto, Takeharu Yamanaka, Kazuko Matsumoto, et al.. (2011). Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma. Journal of Thoracic Oncology. 6(11). 1889–1894. 5 indexed citations

17.

Ishiguro, Takashi, Kazuo Kasahara, Hideharu Kimura, Masahide Yasui, & Masaki Fujimura. (2007). Diabetes Insipidus Induced by Metastasis of Lung Adenocarcinoma to Pituitary Gland -Case Report-. Haigan. 47(2). 125–130.

18.

Kimura, Hideharu, Hisao Fukumoto, Sarah Park, et al.. (2005). Deletional mutant EGFR detected in circulating tumor-derived DNA from lung cancer patients treated with gefitinib.. Cancer Research. 65. 112–112.

19.

Yonemura, Yutaka, Itasu Ninomiya, A Yamaguchi, et al.. (1991). Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.. PubMed. 51(3). 1034–8. 270 indexed citations

20.

Yamaguchi, Yoshiko, et al.. (1985). [Serum neuron-specific enolase as a marker of lung cancers].. PubMed. 12(1). 139–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact